AKT1 and renal carcinoma: In renal cancer cells, overexpression of METTL3 leads to decreased PI3K/AKT activation as well as suppressed tumor growth (17), suggesting a PI3K/Akt-dependent regulatory function of m6A modification in ccRCC.